1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial
Appelgren, Matilda ; Sackey, Helena ; Wengström, Yvonne ; Johansson, Karin LU ; Ahlgren, Johan LU ; Andersson, Yvette ; Bergkvist, Leif ; Frisell, Jan ; Lundstedt, Dan and Rydén, Lisa LU
, et al.
(2022)
In Breast
63.
p.16-23
- Contribution to journal › Article
- 2020
-
Mark
The generalisability of randomised clinical trials : an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer
de Boniface, Jana ; Ahlgren, Johan ; Andersson, Yvette ; Bergkvist, Leif ; Frisell, Jan ; Lundstedt, Dan ; Olofsson Bagge, Roger ; Rydén, Lisa LU
and Sund, Malin
(2020)
In Breast Cancer Research and Treatment
180(1).
p.167-176
- Contribution to journal › Article
- 2017
-
Mark
Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malmö, Stockholm, and Göteborg
- Contribution to journal › Article
-
Mark
Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection : The randomized controlled SENOMAC trial
de Boniface, Jana ; Frisell, Jan ; Andersson, Yvette ; Bergkvist, Leif ; Ahlgren, Johan ; Rydén, Lisa LU
; Bagge, Roger Olofsson
; Sund, Malin
; Johansson, Hemming
and Lundstedt, Dan
(2017)
In BMC Cancer
17(1).
- Contribution to journal › Article
- 2014
-
Mark
When Is the Deep Inferior Epigastric Artery Flap Indicated for Breast Reconstruction in Patients not Treated With Radiotherapy?
- Contribution to journal › Article
- 2008
-
Mark
Axillary recurrence rate after negative sentinel node biopsy in breast cancer - Three-year follow-up of the Swedish Multicenter Cohort Study
- Contribution to journal › Article